Insulin aspart, recombinant Subcutaneous and Norflex Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Norflex Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Norflex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Norfloxacin
- Insulin aspart, recombinant Subcutaneous-Norgesic
- Insulin aspart, recombinant Subcutaneous-Norgesic Forte
- Insulin aspart, recombinant Subcutaneous-Norgestimate and Ethinyl Estradiol
- Insulin aspart, recombinant Subcutaneous-Norgestrel and Ethinyl Estradiol
- Insulin aspart, recombinant Subcutaneous-Norgestrel, ethinyl estradiol, and ferrous fumarate
- Norflex Injection-Insulin degludec
- Norflex Injection-Insulin Degludec (U-100) Prefilled Pens
- Norflex Injection-Insulin Degludec (U-100) Vials
- Norflex Injection-Insulin Degludec (U-200) Prefilled Pens
- Norflex Injection-Insulin degludec and liraglutide
- Norflex Injection-Insulin degludec and liraglutide Subcutaneous